Galvmed @ 10
Press centre
News
Blog
Vacancies
Contact us
Brucellosis Prize
FMD Project
About us
Our approach
Our aspirations
Our board
Our partners
Our people
Our programmes
Livestock & Diseases
Human & Animal Health
Livestock diseases
Value of livestock
Work
Product development
Commercial development
Enabling Environment
Impact
Monitoring and Evaluation
Value of vaccination
Voices from the field
Publications
Publications
Press centre
News
Blog
Vacancies
Contact us
Brucellosis Prize
FMD Project
Corporate Risk Register (COVID-19)
Home
About us
Find more about GALVmed, our people, mission, vision and our approach to what we do.
Our strategy
Our approach
Our aspirations
Our board
Our partners
Our people
Our programmes
Livestock & Diseases
Find out more about the relationship between human and animal health, the livestock diseases we focus on and the value of livestock in Africa and South Asia.
Human & Animal Health
Livestock diseases
Value of livestock
Our work
Find out about our three areas of work that allow us to provide animal health products to livestock keepers.
Product development
Commercial development
Enabling Environment
Impact
Find out about the value of vaccination, the stories from our partners and the livestock keepers we support and how we measure and evaluate our impact.
Monitoring and Evaluation
Value of vaccination
Voices from the field
Publications
Download information on livestock vaccines, reports, policies, laws and policy players in Africa and South Asia.
GALVdox
Home
News
General
Expression of interest: ASF Vaccine
Back to news
Other news:
GALVmed announces a new programme to tackle low coverage of ruminant vaccination across Africa
GALVmed joins continental meeting on integrating the Progressive Control Pathway for Trypanosomosis into national strategies
Year in Review: GALVmed 2024
Expression of interest: ASF Vaccine
Share this
Please click
here
to download/view document.
